Consolidated Balance Sheets - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Assets
Loans receivable	$ 69,811,335	$ 74,483,463
Interest receivable on loans	1,274,288	1,363,502
Cash	248,874	103,540
Other assets	134,819	59,566
Operating lease right-of-use asset, net	234,793	262,222
Deferred financing costs, net	33,948	7,708
Total assets	71,738,057	76,280,001
Liabilities:
Line of credit	20,670,721	24,994,234
Senior secured notes (net of deferred financing costs of $209,614 and $247,155, respectively)	5,790,386	5,752,845
Deferred origination fees	686,981	669,128
Accounts payable and accrued expenses	231,736	289,868
Operating lease liability	247,287	273,485
Loan holdback	17,500
Dividends payable	1,289,428	1,436,868
Total liabilities	28,934,039	33,416,428
Commitments and contingencies
Stockholders’ equity:
Preferred shares - $.01 par value; 5,000,000 shares authorized; none issued
Common shares - $.001 par value; 25,000,000 shares authorized; 11,757,058 issued; 11,461,585 and 11,494,945 outstanding, respectively	11,757	11,757
Additional paid-in capital	45,542,343	45,535,811
Treasury stock, at cost – 295,473 and 262,113 shares, respectively	(963,745)	(798,939)
Accumulated deficit	(1,786,337)	(1,885,056)
Total stockholders’ equity	42,804,018	42,863,573
Total liabilities and stockholders’ equity	$ 71,738,057	$ 76,280,001